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INTRODUCTION
Obstetric  anaesthesia  has  become  one  of  the  most  important 
subspeciality  which  compose  the  widely  ranging  disciplines  of 
anaesthesia. 
Since  the  days  of  Sir  James  Young  Simpson  and  John  snow, 
pioneers  of  obstetric  analgesia  and  anaesthesia,  modern  obstetric 
anaesthesia has become a very safe and scientific speciality.
Universally,  there  is  an  increase  in  the  incidence  of  cesarean 
sections  due  to  multi-factorial  reasons.  One of  the main  reason is  the 
safety of anaesthetics for cesarean section.
Spinal  anaesthesia  has  a  time  honored place  among the options  of 
anaesthesia for cesarean section. The out standing advantages are 
1. Relative ease of administration of a spinal anaesthetic.
2. Rapidity of onset 
3. Elimination of problems of gastric aspiration and difficult tracheal 
intubation during general anaesthesia.
0.5  %  Bupivacaine  hyperbaric  is  the  commonest  intrathecal  local 
anaesthetic used in our part of the country for cesarean section.
Conduction anaesthesia however poses its own problems of hypotension 
and inadequate analgesia. For adequate analgesia, a high block to at least, 
T4  is  necessary  and  concomitant  vasodilatation  predisposes  to 
hypotension,  even  when  great  care  is  taken  to  avoid  aortocaval 
compression. 
A widely used method of prophylaxis against hypotension developing 
during conduction anaesthesia for cesarean section has been 
1. Use of left uterine displacement 
2. Fluid loading with crystalloids 
Spinal  anesthesia  for  cesarean  delivery  may  be  associated  with 
hypotension  and  fetal  acidosis  (Robert  et  al,  Mueller  et  al).  Many 
different  strategies  have  been  investigated  for  the  prevention  of 
hypotension  (usually  defined  as  a  decrease  in  systolic  blood  pressure 
[SBP] by more than 20%–30% or to < 90–100 mm Hg), but few have 
proven to be consistently reliable. Previously, studies have described the 
use of IV infusions of α agonists to maintain maternal SBP (Ngan et al). 
In those studies,  however, the infusion was started after maternal SBP 
started to decrease, and in some cases there were marked initial periods of 
hypotension (Ngan et al). One recent clinical study (Warwick D. Ngan et 
al)  suggested  that  starting  a  prophylactic  vasopressor  infusion 
immediately  after  the  induction  of  anesthesia  was  more  effective  for 
reducing both the incidence and frequency of hypotension. However, one 
concern of this technique is that relatively large doses of vasopressor is 
likely to be used. Although large doses of drugs such as Phenylephrine 
and metaraminol are likely to be very effective in maintaining maternal 
SBP, they may potentially cause detrimental  effects  on fetal  acid-base 
status because of adverse effects on uteroplacental blood flow. 
In this study, prophylactic infusion of  Phenylephrine 100 µg/min started 
immediately  after  the induction of  spinal  anesthesia  is  investigated.  A 
control  group  received  Phenylephrine  given  by  a  more  conventional 
method in which 100-µg IV boluses were given as treatment for episodes 
of hypotension. The hypothesis that, there would be no detrimental effect 
on  fetal  acid-base  status  despite  the  likelihood  that  large  dose  of 
Phenylephrine would be given when administered by infusion (Ngan et 
al) is also investigated. The main outcome measurement was umbilical 
cord arterial (UA) blood pH, which is the most often measured variable 
as an index of fetal acid-base status (thorp et al).
AIM OF THE STUDY
This  study  was  undertaken  with  the  aim  of  prospectively 
comparing two methods of administration of Phenylephrine, Infusion vs 
Bolus  dose  in  prevention  and  treatment  of  hypotension  in  cesarean 
section under spinal anaesthesia, and to assess the 
1. Incidence and magnitude of hypotension 
2. Incidence of adverse effects
3. Fetal outcome
4. Total dose of Phenylephrine used
HISTORY
‘THE  HISTORY  OF  CESAREAN  SECTION’  published  by 
J.H.Young in 1944 indicates that  cesarean section was practiced upon 
dead pregnant woman. The ancient Roman law, known as ‘Lex Regia’ 
was practiced by second Roman king during 762-715 B.C by which it 
was forbidden to bury the dead body of pregnant women without taking 
out  the  child.  Later  during  the  time  of  Ceaser,  the  law became  ‘Lex 
Caesarea’ and this is the most probable derivation of its present name. 
The term ‘Cesarean section’ was used by James Gullimeau in his book of 
midwifery, published in 1598.
                German obstetrician Sager revolutionized the safe technique of 
cesarean section by introducing his method of suturing the uterus, there 
by reducing the mortality rate considerably.
                  Sir James Young Simpson used Diethyl ether for obstetric 
analgesia on January 1847 and chloroform on 8th November 1847.
                 When John Snow gave chloroform to Queen Victoria during 
the birth of her eighth child, Prince Leopold on 7th April 1853, obstetric 
anaesthesia was rightfully acknowledged by the medical world.
                Soon after Bier gave the first intradural spinal block in 1898 it  
was used in obstetric anaesthesia by Kreis, Doloris, and Malartic between 
1900-1902.  In  1928  Pitkin  published  his  paper  on  controlled  spinal 
anaesthesia in obstetrics.
              Lignocaine was synthesized by Nils Lofgren and Lundquist in 
1943 in Sweden and first used by Gorth in 1948.
              Bupivacaine was synthesized in Sweden by Ekenstam and his 
colleagues in 1957 and used clinically by L.J.Telivuo in 1963.  
              Phenylephrine was first described in 1910 by Barger and Dale. 
ANATOMY OF SUBARACHNOID SPACE
Vertebral canal extends from foramen magnum to the sacral hiatus. 
It protects the spinal cord.
There  are  seven  cervical,  twelve  thoracic  and  five  lumbar 
vertebrae.  The  sacrum  comprises  five,  and  the  coccyx  four,  fused 
segments. The adult spine presents four curvatures: those of the cervical 
and lumbar zones are convex forwards (lordosis), those of the thoracic 
and sacral regions are concave (kyphosis). The former are postural, the 
latter are produced by the actual configuration of the bones themselves. In 
the fetus, there is only a single concave-forward curvature; the cervical 
compensatory curve develops when the newborn infant holds up its head 
and the  lumbar  curve  follows  still  later,  when the  child  sits  and then 
stands.
Although  the  individual  vertebra  have  their  own  features,  they  are 
constructed on a basic pattern as represented by the mid-thoracic vertebra 
the body, through which the weight of the subject is transmitted, and the 
vertebral (or  neural) arch, which surrounds and protects the spinal cord 
lying in the vertebral foramen. The arch comprises a pedicle and a lamina 
on each side, and a dorsal spine. Each lamina, in turn, carries a transverse 
process and superior and inferior articular processes that bear the articular 
facets.  The  pedicles  are  notched;  the  notches  of  each  adjacent  pair 
together form an intervertebral foramen through which emerges a spinal 
nerve. The vertebral column is bound together by several ligaments. They 
are,
1. Supraspinal ligament – passes longitudinally over the tips of the 
spinous processes from C7 to the sacrum.
2. Interspinous ligament – connects the adjoining spinous processes 
together. 
3. Ligamentum Flavum – Known as yellow ligament,  connects the 
adjacent laminae composed of yellow elastic fibers. They become 
progressively thicker from above downwards.
4. Posterior longitudinal ligament – It is on the posterior surface of 
bodies of vertebra.
5. Anterior  longitudinal  ligament  –  It  runs  along  the  front  of  the 
vertebral bodies.
There are seven projections from these vertebras.
They are,
a) Three  muscular  processes  –  (2-Transverse  processes,  1-spinous 
process for the attachment of muscle and ligaments).
b) Four articular processes – Two upper & two lower which in the 
lumbar  region  prevent  rotation  but  allow  limited  flexion  and 
extension between contiguous vertebrae.
Vertebral  canal  formed  by  these  structures  has  deficiencies 
posteriorly in the midline called inter laminar foramina which enlarge in 
flexion  accessible  for  the  passage  of  spinal  needle.  The  direction  of 
spinous process determines the direction of spinal needle.
SPINAL CORD:
It  is  the  direct  continuation  of  the medulla  oblongata  extending 
from the upper  border of  the atlas  to the first  lumbar  vertebra,  below 
which there is leash of nerve roots termed cauda equina. Spinal nerves are 
31 pairs totally. They are 8 Cervical, 12 Thoracic, 5 Lumbar, 5 Sacral, 
and 1 Coccygeal.         
Each of the spinal nerve is composed of anterior and posterior roots 
uniting  at  the  intervertebral  foramina  and  forms  a  nerve  trunk. 
Membranes  covering  the  spinal  cord  from  outside  are  dura  mater, 
arachnoid mater and piamater. Dura and arachnoid mater end at S2 level. 
Piamater is closely applied to the spinal cord.
BLOOD SUPPLY:
It is from the anterior spinal artery which is a branch of vertebral 
artery and also by a pair of posterior spinal arteries which arise from the 
posterior  inferior  cerebellar  arteries.  There  is  no  anastamosis  between 
these arteries.
SPINAL VEINS:
The spinal  veins  are  arranged into anterior  and posterior  plexus 
which are draining into vertebral, azygos and lumbar veins.       
CEREBROSPINAL FLUID:
This is an ultra filtrate of the blood plasma from choroid plexus of 
the lateral ventricles with a pH of 7.32 (7.27-7.37)
It  is  a  clear,  colourless  fluid  found  in  the  cranial  and  spinal 
subarachnoid spaces and in the ventricles of the brain.
The total  volume of CSF in an average adult  ranges from 120-
150ml of which 25-35ml is in the spinal subarachnoid space.
Composition of cerebrospinal fluid:
Specific gravity - 1.006 (1.003-1.009) at 370C  
Pressure - 60-80mm of water
PCO2 - 48mmHg
HCO3- - 23meq/l
Na+ - 133-145meq/l
Cl- - 15-20mg/dl
Sugar - 45-80mg/dl
Ca+ - 2-3meq/l
PO4- - 1.6mg/dl
Mg+ - 2-2.5mg/dl
Lymphocytes - 0-5cells/cu mm
Protein - 23-38mg/dl
             An important factor that determines the spread of drug in 
cerebrospinal  fluid  is  the  density  of  the  drug  in  relation  to  that  of 
cerebrospinal fluid (Baricity) which is 1.003-1.009. Hyper baric solution 
is one which is denser than CSF at 370C. 
PHYSIOLOGY OF SUBARACHNOID BLOCK
Subarachnoid  block implies  the  temporary  interruption  of  nerve 
transmission  within  the  subarachnoid  space  by  injections  of  local 
anaethetics.  The  blockade  of  nerve  fibres  occur  in  the  order  of 
temperature, pain, proprioceptive and then motor fibres.  
FACTORS INFLUENCING BLOCK HEIGHT:
a - Site of injection 
b - Angulation of needle 
c - Characteristic of local anaesthetic
d - Dose of local anaesthetic
e - Position of the patient during and after injection
f - Anatomic configuration of spinal column.
g - Patient height (at extremes)
h - Volume of cerebrospinal fluid
i - Reduced cerebrospinal fluid with increased intra abdominal 
  pressure (eg. Pregnancy)
a) Effects on Cardio Vascular System:   
Most  important  physiological  responses  to  subarachnoid  block 
involve cardio vascular system which is due to autonomic denervation. 
Local anaesthetics and vasoactive substances administered in small 
doses intrathecally leads to direct cardiovascular effect.
Level  of  sympathetic  denervation  determines  the  magnitude  of 
cardio  vascular  system  responses,  but  the  relationship  is  neither 
predictable nor precise.
Sympathetic  denervation  produces  arterial  and  more 
physiologically  important  arteriolar  dilatation and vasodilatation in the 
venous circulation produces fall in blood pressure.
Due to Bainbridge reflex, the fall in blood pressure is associated 
with bradycardia; blockade of cardiac sympathetic fibre from T1-T4 is an 
additional factor that causes bradycardia. 
b) Effects on Respiratory System:
Respiration  is  not  depressed  normally.  High  spinal  can  cause 
paralysis  of  intercostal  muscles  but  resting  tidal  volume,  maximum 
inspiratory volume, respiratory rate, ABG, negative intrapleural pressure 
and  also  the  phrenic  nerve  are  unaffected.  Hypoxia  may  accompany 
hypotension and is corrected by oxygen administration via face mask.
c) Gastro Intestinal Effect:
Preganglionic  fibres  from  T5-L1 are  inhibitory  to  gut.  So  in 
sympathetic blockade the small intestine contracts with relaxed sphincters 
and peristalsis  remains  normal.  Handling of  viscera  causes  discomfort 
and bradycardia since vagus is not blocked.
d) Hepatic and Renal Effects:
The hepatic blood flow decreases and is directly proportional to the 
decrease  in  blood  pressure.  There  may  be  normal  hepatic  oxygen 
extraction. Renal blood flow is maintained by auto regulation and does 
not decrease till mean arterial pressure goes below 50mmHg.
e) Genito Urinary System:          
Sphincters of bladder are not relaxed, and tone of the ureter is not 
greatly altered. Urinary retention occurs. Penis is often engorged. Uterine 
tone is unchanged in pregnancy. In the absence  of  hypotension spinal 
anaesthesia has got no effect on the progress of labour and uterine blood 
flow. 
f) Metabolic and hormonal effect:
Spinal  anaesthesia  blocks  hormonal  and  metabolic  responses  to 
nociceptive stimuli arising from the operative site. It minimizes the rise in 
blood  sugar,  coritsol,  catecholamine,  renin  and  aldosterone  release 
associated  with  stress.  Post  operative  negative  nitrogen  balance  and 
secretion of antidiuretic hormone are inhibited. 
g) Thermo Regulation:
Hypothermia results from heat loss to the cold environment due to 
vasodilatation.
ANATOMICAL AND PHYSIOLOGICAL ANAESTHETIC 
IMPLICATIONS IN PREGNANT PATIENTS
Maternal changes in pregnancy occur as a result of:
Hormonal alterations
Mechanical effects of the gravid uterus
Increased metabolic and O2 requirements
Metabolic demands of the fetoplacental unit
Hemodynamic alterations associated with the placental circulation. 
CARDIOVASCULAR SYSTEM:               
Stimulus behind Cardiovascular changes is mainly endocrine
CARDIAC OUTPUT:
Increases from 5th week, and the maximal levels are reached at 32 
weeks.50% of the increase in cardiac output occurs at 8th week.     
Cardiac output is the product of  heart rate and stroke volume.
Heart rate increases by 20- 30 % and stroke volume increases by 
20- 50 %
BLOOD PRESSURE:
 Gradual  fall  in  blood  pressure  occurs,  systolic  blood  pressure 
decreases by 5-10 mmHg and diastolic blood pressure decreases 
by10-15mmHg, so there is an increase in pulse pressure.
VASCULAR RESISTANCE:
There is a decrease in systemic vascular resistance by 20% and a 
decrease in pulmonary vascular resistance by 30 %. Decrease in 
systemic vascular resistance causes a low resistance utero placental 
circulation. Blood flow to organs is not uniform, uterus receives 
700-800 ml/min which is10 % of cardiac output, and blood supply 
to breast doubles which is 2% of cardiac output. 
AORTOCAVAL COMPRESSION:           
After 20 weeks of pregnancy, the enlarged uterus compresses the 
IVC in supine position so there is a decrease in venous return to the heart. 
SUPINE HYPOTENSION SYNDROME:
Characterized  by  hypotension,  nausea,  vomiting,  sweating  & 
pallor.  Gravid  uterus  also  compresses  the  aorta  in  supine  position  so 
decrease  in  blood  flow  to  lower  extremities  and  uteroplacental 
circulation. Aortocaval compression is an important preventable cause of 
fetal  distress.  Anaesthetics  and  drugs  that  cause  vasodilatation  or 
techniques  that  cause  sympathectomy  increase  the  aortocaval 
compression. Parturients with 20 weeks or longer gestation should not be 
placed supine without left uterine displacement, accomplished by placing 
a wedge (>15°, CARDIFF’S WEDGE) under the right hip. 
Parameter            Change Amount (%)
Heart rate Increased 20–30
Stroke volume Increased 20–50
Cardiac output Increased 30–50
Contractility Variable ±10
CVP Unchanged -
PCWP Unchanged        -
SVR Decreased 20
  SBP Slight decrease Mid trimester ,10–15 
PVR Decreased 30
PAP Slight decrease -
LABOUR: 
Cardiac output increases further in labour, basal cardiac output in 
between uterine contractions increases by 13% in Ist stage of labour. Late 
in  Ist  stage  of  labour  cardiac  output  increases  by  34%  with  each 
contraction.
PUERPERIUM:
Cardiac output remains elevated for the Ist 24 hrs after delivery, 
and then falls progressively. Cardiac output decreases by 28% by 2 weeks 
after  delivery,  with  20% reduction  in  heart  rate  and 18% decrease  in 
stroke volume.
 ECG: 
ECG  shows  left  axis  deviation,  right  bundle  branch  block,  ST 
segment depression of 1 mm on left precordial leads, Q waves in lead III 
,T-wave inversion in leads III, V2 , and V3
CHEST RADIOGRAPHY:
Apparent cardiomegaly, Enlarged left atrium (lateral views),
Increased vascular markings, straightening of left-sided heart 
border, postpartum pleural effusion
HAEMATOLOGY:
 BLOOD VOLUME:
An earliest and most fundamental change in pregnancy is increase 
in blood volume which is detectable at 6th week, which is greatest during 
the II trimester and reaches a plateau at 34- 36 weeks. At term, blood 
volume increases  by 48% more  than non pregnant values.  Trigger for 
increase in blood volume is hormonal. By term, plasma volume increases 
by upto 45%, whereas red cell volume increases by 30%. This differential 
increase is the cause for physiological anemia of pregnancy. The point of 
greatest  difference  being  28-30  weeks  of  gestation.  Increase  in  blood 
volume  compensates  for  blood  loss  at  delivery,  which  is  500  ml  for 
vaginal delivery and 800 – 1000 ml for Cesarean section. 
COAGULATION
Pregnancy is  a state  of  hypercoagulability  and platelet  turnover. 
Increased levels of most coagulation factors, Fibrinogen & Factor VII are 
markedly increased. Platelet count is slightly decreased in pregnancy.
PLASMA PROTEINS:
Total plasma protein concentration decreases from 70- 60 gm/litre, 
due to decrease in plasma albumin concentration. The overall  effect  is 
decrease in colloid osmotic pressure and increased risk of oedema. 
PUERPERIUM:
Immediately after delivery, if blood loss is not excessive the blood 
volume increases. At the end of puerperium the blood volume decreases 
to 10% above pre pregnant levels. Plasma albumin and colloid osmotic 
pressure becomes normal with in 6 weeks of delivery.
RESPIRATORY SYSTEM
Marked  changes  in  respiratory  system  occur  in  tandem  with 
changes in cardiovascular system which causes increased O2 uptake and 
CO2 elimination.
ANATOMY:
Generalized vasodilatation of skin and mucous membrane due to 
progesterone  mediated  relaxation  of  vascular  smooth  muscle  occurs. 
Capillary engorgement of nose, oropharynx and larynx occurs, and voice 
change and difficulty with nasal breathing also occurs.
ANTICIPATED DIFFICULT INTUBATION
There is predisposition of upper airways to trauma, bleeding and 
obstruction, so gentle laryngoscopy and use of small ETT is advised (6.0- 
7.0).  Diaphragm is  elevated 4 cm by uterine enlargement.  Increase  in 
chest wall circumference by 5-7 cm. Subcostal angle increases from 68° 
to 103°. Diaphragmatic movements are not hindered. Abdominal muscles 
are less active
LUNG VOLUMES
Tidal volume increases with gestation, and by term the increase is 
40% more than non pregnant women. Vital capacity remains unchanged, 
respiratory  rate  increases  by  15%,  and  total  lung  capacity  is  slightly 
decreased. Minute volume increases by 40%, and changes are detectable 
by 6th week and these changes are due to progesterone. There is increased 
alveolar ventilation; VD/VT remains unchanged, increased physiological 
dead space. Functional residual capacity (FRC) decreases, this decrease 
starts from II trimester, and at term it decreases by 20%. Closing capacity 
(CC) remains unchanged. O2 consumption increases by 20- 50% due to 
increased demands.  Respiratory quotient increases from a pre pregnant 
value of 0.76 to 0.83 in late pregnancy .Combination of decreased FRC, 
increased VO2, decreased FRC/CC ratio causes a rapid O2 desaturation 
during periods of apnea. 
CENTRAL NERVOUS SYSTEM:
There  is  increased  sensitivity  to  both  general  and  regional 
anaesthetics. Minimum alveolar concentration is progressively decreased 
during pregnancy by 40%.
Causes:  
1. Maternal hormone like progesterone
2. Endogenous opioid
3. Surge in β  endorphin levels during labour and delivery
Enhanced  sensitivity  to  local  anaesthetics  during  regional 
anaesthesia, so the dose is reduced by 30% .Neural blockade occurs at 
lower concentration of local anaesthetics.
RENAL SYSTEM:
Renal blood flow increases by 80% in early pregnancy and falls to 
60%  in  III  trimester  due  to  relative  hypervolemia  of  pregnancy  and 
increased secretion of hormones. GFR increases by 50% due to dilutional 
effect of plasma volume expansion so decreased plasma creatinine and 
urea. “Hence normal renal indices in pregnancy are lower than in the non 
pregnant state.” 
GASTROINTESTINAL SYSTEM          
Generalized relaxation and decreased motility of gastro intestinal 
tract.  Hypersecretion  of  gastric  acid  occurs  and  gastric  emptying  is 
delayed. With a gastric pH of less than 2.5 and gastric volume of more 
than 25 ml, there is an increased risk of aspiration pneumonitis.
“SO ALL PARTURIENTS ARE CONSIDERED TO BE HAVING 
FULL STOMACH. THEREFORE   RAPID SEQUENCE INTUBATION 
AND SELLICK’S MANEUVER SHOULD BE APPLIED”.
Opioids  and  anticholinergics  decrease  lower  esophageal  sphincter 
pressure  which  facilitates  gastro  esophageal  reflex  and  delays  gastric 
emptying.
METABOLIC EFFECTS:       
 Pregnancy  is  an  accelerated  state  of  starvation,  so  there  is 
decreased blood glucose and amino acid levels, increased free fatty acids, 
triglycerides and ketones. Pregnancy is a diabetogenic state so increased 
insulin secretion occurs. Glucose crosses placental barrier by facilitated 
diffusion.  Thyroid enlargement  is  by  relative  hyper  stimulation  of  the 
gland by human chorionic gonadotropin and increased thyroid binding 
globulin.  Increased  Total  T4  and  T3.  Free  T4,  T3  and  TSH remains 
normal, serum calcium is decreased and ionized calcium is normal.
PHARMACOLOGY OF DRUGS
a) Bupivacaine:
Bupivacaine  is  an  amide  linked  local  anaesthetic.  It  is  a 
hydrochloride  salt  of  1-butyl-N-(2,  6-  dimethylphenyl)  piperidine-2-
carboxamide and is presented as a racemic mixture.
 It was synthesized by Ekenstam and Egner
 First reports of its use were published in 1963 by Telivuo.
 It is derived from Mepivacaine and is very stable compound and 
may be autoclaved repeatedly.
Pka is - 8.1
Molecular weight - 288 
Protein binding - 95%
Lipid solubility - 28
Elimination half life - 210mts
Toxic plasma concentration- >1.5µg/ml
Approximate duration of action - 175mts
Availability:
Ampoules - 0.5% Bupivacaine hydrochloride with dextrose 
(Heavy) 4cc
-       0.5% Bupivacaine hydrochloride 4cc (plain)
Vials -       0.25% and 0.5% Bupivacaine hydrochloride 20cc
Dosage - Maximum dosage 3mg/kg body weight.
Uses:
 Spinal anaesthesia
 Epidural anaesthesia
 Caudal anaesthesia
 Continuous epidural anaesthesia
 Peripheral nerve block
Onset time and duration of action
Site of action Onset (minutes) Duration (minutes)
Intrathecal 5 90-120
Epidural 15-20 165-225
Brachial plexus 15-20 600
Pharmacokinetics:
Once injected intrathecaly, it gets absorbed by the nerve rootlets 
and results in the desired effect. It is rapidly absorbed from the site of 
injection, but the rate of absorption depends on the vascularity at the site 
and presence of vasoconstrictors.
High lipid solubility of bupivacaine makes it easy for nerve and 
vascular tissue penetration. 
80-95% of the absorbed bupivacaine binds to the plasma proteins.
Distribution:
Rapid distribution phase: (α)
In this phase the drug is distributed to highly vascular region. t1/2 
of α - being 2.7 minutes.     
Slow disappearance phase: (β)
In this phase the drug distributes to slowly equilibrating tissues. 
t1/2 of β – being 28mts. 
Biotransformation and excretion phase: (δ) 
T1/2 of δ is 3.5hours clearance is 0.47 litre/minute.
Biotransformation:
Possible pathways of metabolism of bupivacaine include aromatic 
hydroxylation and conjugation.  Only  the  N-dealkylated  metabolite,  N-
desbutyl bupivacaine has been measured in blood (or) urine after epidural 
(or) spinal anaesthesia. Alpha1 acid glycoprotein is the most important 
plasma  protein  binding  site  of  bupivacaine  and  its  concentration  is 
increased by many clinical situations including post operative trauma.
Excretion:
It is through the kidney; 4-10% of the drug is excreted unchanged.
Mode of Action:
a) Site of action:
i) The  spinal  nerve  rootlets,  fine  nerve  filaments  having  a  large 
surface area are exposed to the local anaesthetics. 
ii) Posterior and lateral aspects of the spinal cord itself.
b) Sodium Channel blockade:
They impede sodium ion access to the axon interior by occluding 
the  transmembrane  sodium  channels  thus  delaying  the  process  of 
depolarization  and  axon  remains  polarized.  It  is  a  non-depolarization 
blockade.    
Pharmacodynamics:
It has got a longer duration of action but a slower onset.
Cardio vascular system:
It  reduces  cardiac  output  by  reducing  the  sympathetic  tone,  by 
slowing the heart rate and by reducing the venous return, it produces a 
fall in arterial blood pressure but it is relatively slow and is seldom very 
profound.
It produces a fall in central venous pressure. It causes an increase 
in lower limb blood flow. It causes a reduction in incidence of deep vein 
thrombosis.
Respiratory System:
Spinal blockade seldom, if ever causes respiratory problem.
Gastro intestinal tract:
There is an increase in gastro intestinal motility and emptying of 
the gastric contents is better.  
 Toxicity:
Toxicity is related to plasma level of unbound drug and more likely 
due to an inadvertent intravenous injection. Systemic toxicity reactions 
primarily involve central nervous system and cardio vascular system. The 
blood level required to produce central  nervous system toxicity is less 
than that required to produce circulatory collapse. 
Central Nervous System Toxicity:   
Initial symptom includes feeling of light headedness and dizziness, 
followed  by  visual  and  auditory  disturbances.  Objective  signs  are 
excitatory and include shivering, muscle twitching and tremor. Ultimately 
generalized tonic, clonic seizures occurs.
Cardiovascular System Toxicity:
The  rate  of  depolarization  in  fast  conducting  tissue  of  purkinje 
fibres  and  ventricular  muscle  is  decreased.  The  rate  of  recovery  of 
bupivacaine induced block is slower than that of lignocaine. Extremely 
high  concentration  of  the  drug  causes  sinus  bradycardia  and  cardiac 
arrest.
b) Pharmacology of Phenylephrine:
 It was first described in 1910 by Barger and Dale
 Synthetic noncatecholamine  
 Also called as neosynephrine
 Stimulates α1 adrenergic receptors by a direct effect
 Small  part of pharmacologic response being due to its ability to 
evoke the release of norepinephrine ( indirectly acting)
Dose of Phenylephrine necessary to stimulate α1 receptor is far less than 
the dose that stimulates  α2 receptor, so venoconstriction is greater than 
arterial constriction 
STRUCTURALLY:  
          It  differs  from epinephrine in lacking a 4-hydroxylgroup on 
benzene ring 
Clinically Phenylephrine mimics the effects of norepinephrine but 
is less potent and longer lasting
PHARMACOKINETICS:
 Response to subcutaneous dose takes 10 minutes
 Response to intramuscular dose takes 15 minutes
Duration of action to subcutaneous dose is 1 hour
Duration of action to intramuscular dose is 2 hours
I.V injection is effective for upto 20 minutes
Metabolized in liver by Mono amine Oxidase (MAO) an enzyme 
which is present in the gastrointestinal tract and the liver
AVAILABILITY:
Ampoule - each ml contains 10 mg Phenylephrine hydrochloride
Available as 1 ml 
 Vials - available as 5 ml vial
CONTRAINDICATIONS:
Hypersensitivity  to  Phenylephrine  or  any  component  of  the 
formulation causes hypertension and ventricular tachycardia.
Oral : not to be used within 14 days of MAO inhibitor therapy
Ophthalmic : avoided in narrow-angle glaucoma
CLINICAL USES:
            Phenylephrine, 50 to 200 µg IV to treat blood pressure decreases 
that  accompany  sympathetic  nervous  system  blockade  by  regional 
anaesthetic  or  peripheral  vasodilatation  which  accompanies 
administration of injected or inhaled anaesthetic.
         Useful in patients with CAD and in patients with aortic stenosis 
because  this  drug in  contrast  to  other  sympathomimetics  increases  the 
coronary perfusion pressure without chronotropic side effects.
         Topically administered Phenylephrine is a nasal decongesant and 
produces mydriasis without cycloplegia.
           Phenylephrine like epinephrine is effective in prolonging spinal 
anaesthesia when added to local anaesthetic solution that is placed in the 
subarachnoid  space. Phenylephrine  prolongs  spinal  anesthesia  with 
tetracaine, Tetracaine + Phenylephrine the duration is 406 ± 63mins (5 
mg) compared to tetracaine alone 273 ± 90 mins. Phenylephrine has been 
used in epidural anesthesia less widely than in spinal anesthesia, perhaps 
because  it  does  not  reduce  peak  blood  levels  of  local  anesthetic  as 
effectively as epinephrine does during epidural use.
In  obstetric  anaesthesia  Phenylephrine  is  associated  with  a  higher 
umbilical artery pH at delivery than ephedrine.
EYE:
Phenylephrine is an α-adrenergic agonist applied topically to dilate 
the pupil.
 Systemic absorption of the 10% solution is associated with severe 
hypertensive  reactions.  The  2.5%  concentration  is  safer,  but  may 
exacerbate hypertension in some patients.
Narrow angle glaucoma is a contraindication to Phenylephrine use.
NASAL DECONGESANT:
Topical  vasoconstrictor  alone  or  in  combination  with  lidocaine. 
Guidelines on the topical use of Phenylephrine in the operating room 
recommend the following: 
 1.     Initial phenylephrine dose should not exceed 0.5 mg, and in 
 children weighing 25 kg or less, it should not exceed 20 µg/kg. 
   2.     Blood pressure and pulse should be closely monitored. 
   3.     The dose should be administered in a calibrated syringe and
          should be verified by a physician. 
   4.     The anesthesiologist should be aware of all medications given. 
   5.     Severe hypertension should be treated immediately with direct
           vasodilators or α-receptor antagonists. 
   6.  β-Receptor blockers and calcium channel blockers should be 
avoided. They can worsen cardiac output and result in pulmonary 
edema. 
   7.     If a β-receptor blocker is used to treat hypertension, glucagon 
 administration  should  be  considered  to  counteract  the  loss  of 
cardiac contractility.
SIDE EFFECTS:
Cardiovascular system: 
                Rapid I.V injection of Phenylephrine to patients with coronary 
artery disease produces dose dependent peripheral vasoconstriction and 
increase in systemic blood pressure that are accompanied by decrease in 
cardiac output. In spite of reduction in cardiac output there is an increase 
in  coronary  blood flow.  Decreased  cardiac  output  is  due  to  increased 
afterload (constriction), and reflex mediated bradycardia.
             Renal, splanchnic and cutaneous blood flows are decreased. 
Pulmonary artery pressure is increased 
 Metabolic effects:
              Stimulation  of  α receptors  by a  continuous infusion of 
Phenylephrine  during  acute  potassium  loading  interferes  with  the 
movement of potassium ions across cell membrane into cells.
TREATMENT OF OVER DOSE:
               Systemic hypertension induced by topically applied or injected 
α  agonists  may  not  require  treatment.  The  duration  of  action  of 
Phenylephrine  and  Epinephrine  is  brief  and  hypertension  may  resolve 
spontaneously without pharmacologic interventions.
              In case of severe hypertension, vasodilating drugs such as 
nitroprusside or nitroglycerine is recommended.
NEURAXIAL ANAESTHESIA AND FETAL ACIDOSIS
The use of neuraxial anesthesia has dramaticaly increased, and data 
suggest that the use of general anesthesia for cesarean section has been 
steadily  decreasing.   Neuraxial  anesthesia  techniques  have  several 
advantages, including a decreased risk of failed intubation and aspiration 
of gastric contents, avoidance of depressant agents, and the ability of the 
mother  to  remain  awake  and  enjoy  the  experience  of  child  birth.  In 
addition, it has been suggested that blood loss is reduced under regional 
anesthesia for cesarean delivery.
Although epidural, spinal, continuous spinal and CSE techniques 
have all been advocated, most straightforward cesarean sections are now 
performed with single-shot spinal anesthesia, which has been found to be 
faster, provide a superior block, and are more cost effective, especially as 
compared with epidural anesthesia.
SPINAL ANESTHESIA: Spinal (subarachnoid) anesthesia offers many 
advantages for cesarean delivery. It has a very rapid onset and provides a 
dense neural block. Because of the small doses used, there is little risk of 
local anesthetic toxicity and minimal transfer of drug to the fetus. In 
addition, failures (including incomplete or patchy blocks) are very 
infrequent with spinal anesthesia. Disadvantages of this technique include 
the definite duration of anesthesia and a higher incidence of hypotension.
    The  major  adverse  fetal  effect  of  regional  anaesthesia  and  its 
sympathetic blockade is uteroplacental hypoperfusion, which leads to an 
acute fall in intervillous blood flow with the potential for fetal acidemia. 
The type of fetal acidemia associated with anaesthesia of any method, 
including general anaesthesia, is predominantly “Respiratory,” suggesting 
that  an  acute  event  is  the  proximate  cause  of  the  fetus’s  acid-base 
condition. Specifically, PaCO2 values increased significantly in acidemia 
fetuses. Metabolic acidemia is rare in the acute causes of hypotension.
SAMPLING PROCEDURE:  Umbilical cord blood analysis is assumed 
to give a picture of the acid–base balance of the infant at the moment of 
birth when the umbilical circulation is arrested by clamping of the cord. 
However,  from  this  moment  onwards  the  umbilical  cord  blood,  if  it 
remains in continuity with placenta, will demonstrate progressive change 
in  acid–base  status  due  to  ongoing  placental  metabolism  and  gas 
exchange.  Small  changes  in  umbilical  pH occur  within 60 seconds  of 
delivery, and over 60 minutes cord arterial or venous pH can fall by more 
than 0.2 pH units. Similar changes occur in blood sampled from placental 
surface  vessels  except  that  they are  larger  and less  predictable.  These 
changes are not observed if the cord is doubly clamped at birth, isolating 
a segment of cord blood from both the placenta and the environment. The 
umbilical  vein  is  larger  and easier  to  sample  from than  the  umbilical 
artery,  and  when  only  a  single  sample  can  be  obtained  because  of 
sampling  difficulties  it  is  likely  to  be  venous. So  paired  samples  are 
obtained. 
WHAT  IS  A  NORMAL  CORD  pH?  :  Many  authors  have  studied 
normal  umbilical  blood  biochemistry  and  acid–base    status.  Most 
available  data  relate  to  infants  born  at  full  term.  Parity,  breech 
presentation, mode of delivery and many other factors influence cord gas 
values.
Umbilical 
artery pH
PCO2 (kPa)
Umbilical 
vein pH
PCO2 (kPa)
Victory et al 2004 7.24 7.33
Thorp et al  1989 7.24 6.69 7.32 5.83
Helwig et al 
1996
7.26 7.05 7.34 5.45
Dickinson et al 
1992
7.26 7.05 7.33 5.77
Riley and 
Johnson1993
7.27 6.69 7.34 5.41
Umbilical cord blood gas analysis is recommended in all high-risk 
deliveries  and  is  performed  after  all  deliveries  in  some  centres.  For 
optimal  interpretation  paired  umbilical  arterial  and  venous  samples 
should be taken soon after birth from a segment of cord that has been 
doubly clamped to isolate it from the placenta. Low cord pH in infants 
who are vigorous at birth and free of cardiopulmonary compromise does 
not indicate an increased risk of adverse outcome. Infants with pH ,7.0 at 
birth  who  are  not  vigorous  are  at  high  risk  of  adverse  outcome. 
Identification of infants at risk of encephalopathy is especially important 
now  that  early  intervention  is  being  considered.  Analysis  of  paired 
arterial and venous specimens can give insights into the aetiology of the 
acidosis.  In combination with other clinical information,  normal paired 
arterial and venous cord blood gas results can usually provide a robust 
defense against a suggestion that an infant had an intrapartum hypoxic-
ischaemic event.
REVIEW OF LITERATURE
1. Rout  CC  et  al  (1992)  concluded  that  Rapid  administration  of 
crystalloid preload does not decrease the incidence of hypotension after 
spinal  anaesthesia  for  elective  Caesarean section.  They found that  pre 
loading  of  1  litre  of  crystalloid  solution  infusion  during  the  10  min 
preceding the administration of spinal anaesthesia for cesarean section in 
combination with a prophylactic infusion of ephedrine did not reduce the 
incidence, severity, duration of hypotension.
2. Thomas et al (1996) did randomized trial of bolus Phenylephrine or 
ephedrine for maintenance of arterial pressure during spinal anaesthesia 
for Caesarean section, Thirty-eight healthy women undergoing elective 
Caesarean  section  under  spinal  anaesthesia  at  term  were  allocated 
randomly to receive boluses of either Phenylephrine 100 micrograms or 
ephedrine  5  mg  for  maintenance  of  maternal  arterial  pressure.  Mean 
umbilical  artery  pH [95% CI]  was  higher  in  the Phenylephrine  group 
(7.29 [7.28-7.30])  than in the ephedrine group (7.27 [7.25-7.28]).  The 
results  of  the  present  study  support  the  use  of  phenylephrine  for 
maintenance  of maternal  arterial pressure during spinal  anaesthesia  for 
elective cesarean section.
3. HALLet al (1994) compared infusions of phenylephrine and ephedrine 
and   infusion of  Phenylephrine 10 µg min–1 with bolus doses of 20 µg 
was  shown  to  be  significantly  more  effective in maintaining  systolic 
arterial pressure within 20% limits of baseline compared with an infusion 
of ephedrine 1 or 2 mg min–1 with bolus doses of 6mg .
4. Cooper et al, studied the effect of intravenous vasopressor on spread of 
spinal  anaesthesia  and  fetal  acid–base  equilibrium.  It  was  found  that 
rostral  spread  of  spinal hyperbaric  bupivacaine to  be  less  with 
prophylactic phenylephrine than with ephedrine. It was observed that an 
unexpectedly high  incidence of fetal acidosis with ephedrine and found 
evidence  that  longer  spinal-delivery intervals  increase  the  risk of  fetal 
acidosis developing with ephedrine, but not phenylephrine. 
5. Afshari et al (2006) Compared prophylactic infusion of ephedrine and 
phenylephrine during Cesarean section under spinal anaesthesia.  Spinal 
anaesthesia for caesarean delivery may be associated with hypotension 
and fetal  acidosis.  Prophylactic  infusion of  phenylephrine immediately 
after the induction of anaesthesia appears to be a more effective approach 
than administration of ephedrine to reduce the incidence, frequency and 
severity  of  hypotension.  Furthermore,  Phenylephrine  appears  to  be 
associated with better fetal acid-base status than is ephedrine.
6. Moran et al(1999) studied about  Phenylephrine in the prevention of 
hypotension following spinal anesthesia for cesarean delivery. Here the 
maternal venous, umbilical artery, and umbilical vein blood gases were 
measured, and neonatal Apgar scores and early neonatal neurobehavior 
scale scores were assessed. In the ephedrine group, umbilical artery pH 
was  7.28  ±  0.01  (mean  ±  SEM),  umbilical  artery  partial  pressure  of 
carbon dioxide (PCO2) was 56.6 ± 1.4 mmHg, and umbilical artery base 
deficit was 2.2 ± 0.04 meq. In the phenylephrine group, umbilical artery 
pH was 7.32 ± 0.01, umbilical artery PCO2 was 52.1 ± 1.3 mm Hg, and 
umbilical artery base deficit was 0.38 ± 0.35 meq. There were significant 
differences between the groups in mean umbilical artery pH, PCO2 and 
base  deficit,  although  all  values  obtained  were  within  normal  limits. 
There  were  no  significant  differences  between  the  groups  in  the 
remaining  acid-base  values,  neonatal  Apgar  scores,  early  neonatal 
neurobehavior  scale  scores,  or  frequency  of  maternal  nausea  and 
vomiting.  It  was  concluded  that  Phenylephrine  is  as  effective  as 
ephedrine in the treatment  of maternal  hypotension,  and when used in 
small incremental bolus injections, it appears to have no adverse neonatal 
effects in healthy, nonlaboring parturients.
7. Mercier et al,(2001) studied about Phenylephrine added to prophylactic 
ephedrine infusion during spinal anesthesia for elective cesarean section, 
hypotension  occurred  less  frequently  in  the  ephedrine-phenylephrine 
group than in the ephedrine alone group: 37%versus 75% (P = 0.02). 
Ephedrine (36 ±16 mg, mean ± SD) plus 178 ±81 μg phenylephrine was 
infused in former group, whereas 54 ±18 mg ephedrine was infused in the 
latter.  Median supplemental  ephedrine requirements  and nausea  scores 
(0-3) were less in the ephedrine-phenylephrine group (0  vs. 12 mg,  P = 
0.02; and 0 vs. 1.5, P = 0.01, respectively). Umbilical artery p H values 
were significantly higher in the ephedrine-phenylephrine group than in 
the group that  received ephedrine alone (7.24  vs. 7.19).  Apgar  scores 
were similarly good in both groups. They  concluded that Phenylephrine 
added to an infusion of ephedrine halved the incidence of hypotension 
and increased umbilical cord p H.
8. Schwinn  et  al  (1989)  studied  the  time  course  and  hemodynamic 
effects  of  alpha-1-adrenergic  bolus  administration  in  anesthetized 
patients  with  myocardial  disease.  Phenylephrine  is  frequently 
administered as an intravenous bolus to increase blood pressure, yet 
the  acute  time  course and  hemodynamic  effects  of  bolus 
Phenylephrine  in  patients  with  myocardial disease  have  not  been 
reported.  Therefore  50  randomized  intravenous   bolus doses  of 
Phenylephrine (50, 100, 150, or 200 µg) were given to 18 patients 
during anesthesia for elective coronary artery surgery. Esophageal 
doppler techniques were used to continuously monitor cardiac output 
(CO); mean arterial pressure (MAP), CO, and calculated systemic 
vascular resistance (SVR) were recorded every 5 seconds for a total 
of 2 minutes. CO (–.58 ± 11, –.68 ± .13, –.73 ± 20, –.77 ± 18 Lmin–
1). Hypertension, increased age, low preoperative ejection fraction, 
high baseline CO, and low baseline SVR significantly (P < 0.05) 
decreased hemodynamic responses to Phenylephrine .In conclusion, 
bolus IV  Phenylephrine  in  patients  with  myocardial  disease 
increases MAP and SVR and simultaneously decreases CO; these 
peak  hemodynamic events  occur  approximately  42  seconds  after 
Phenylephrine administration.
9. Stephen et al (2001) studied the effects of an increase of central blood 
volume before spinal anesthesia for cesarean delivery: A qualitative 
systematic review, he performed a systematic review to determine 
whether fluid loading reduced the incidence of low blood pressure 
after spinal anesthesia for cesarean delivery. It was concluded in the 
study  that  no  technique totally  eliminates  the  occurrence  of 
hypotension,  colloid  administration (starch  or  gelatin  containing 
fluids) and leg wrapping were the most effective.
10. Brooker et al (1997) studied about the treatment of hypotension after 
hyperbaric tetracaine spinal anesthesia: A randomized, double-blind, 
cross-over  comparison  of  Phenylephrine  and  Epinephrine,  and 
concluded  that  Epinephrine  management  of  tetracaine  induced 
spinal  hypotension  increases  heart  rate  and  cardiac  output  and 
restores  systolic  arterial  pressure  but  does  not  restore  mean  and 
diastolic  blood pressure.  Phenylephrine management  of  tetracaine 
spinal-induced hypotension decreases heart rate and cardiac output 
while restoring systolic, mean, and diastolic blood pressure.
MATERIALS AND METHODS
After  getting the approval from the ethical committee,  the study 
was conducted in 100 patients, who all were primi gravidas undergoing 
emergency  cesarean  section.  After  getting  consent  and  explaining  the 
procedure details, the anaesthetic technique was performed.
SELECTION OF PATIENTS:
                   The patients selected for this study were of ASA Risk I. It 
was a randomized double blinded study.  The usual indications for the 
cesarean section were cephalopelvic disproportion, breech presentation, 
and premature rupture of membranes. Patients exhibiting the following 
were excluded from the study.
- Diabetes mellitus 
- Pregnancy induced hypertension
- Obesity
- Multiple pregnancy
- Cardiac disease
- Coagulopathy
- Renal impairment
Age group:
  Age of the patients ranged from 18 to 30 yrs
METHOD OF STUDY:
The following anaesthetic equipments and drugs were kept ready 
before the performance of subarachnoid block.
 Boyles machine with oxygen cylinder
 Laryngoscope with blades of various sizes
 Airway and endotracheal tubes in all sizes
 Suction apparatus 
 Emergency  drugs  like  ephedrine,  dopamine,  atropine  and 
adrenaline
PROCEDURE DETAILS:
The  preoperative  baseline  parameters  like  pulse  rate,  blood 
pressure, respiratory rate were recorded. Three readings were taken and 
the average of  the three was taken as the mean baseline value of  the 
patient.
 IV line started with 18 gauge intravenous cannula and the patient 
was infused with Ringer lactate solution at the rate of 5 ml per minute. 
They  are  premedicated  with  Inj.  Ranitidine  50  mg  and 
Inj.Metoclopramide 10 mg intravenously.
The  subarachnoid  block  was  performed  under  strict  aseptic 
precaution  with  the  patient  in  right  lateral  position  with  a  25  gauge 
Quincke  spinal  needle  in  the  L2-L3  interspace,  and  1.8  ml  of  0.5% 
hyperbaric  Bupivacaine  was  injected  after  ensuring  free  flow  of 
cerebrospinal fluid.
The patients were immediately turned to the supine position with a 
wedge of 10 cm below the right buttock.
The patients were randomly allocated to receive the study drugs, 
either  Phenylephrine  infusion  or  bolus  dose.  In  the  infusion  group, 
Phenylephrine 100µg /min was infused for the initial 3 minutes after the 
subarachnoid  block  and  were  supplemented  with  100µg  infusion, 
whenever the systolic blood pressure was below the   baseline value.
In  the  control  group  Phenylephrine  100µg bolus  was  given  when  the 
systolic blood pressure decreased to 20% of the baseline value.
The following were noted and recorded.
1. Pulse rate and blood pressure every one minute until delivery of the 
baby and every five minutes thereafter.
2. The time interval between subarachnoid block to skin incision, skin 
incision  to  uterine  incision,  and  uterine  incision  to  delivery  of 
baby. 
3. APGAR  scores  at  1  minute  and  5  minutes  to  asses  neonatal 
outcome.
4. Total dose of the Phenylephrine used until the delivery of the baby 
in both groups.
5. Total episodes of the hypotension.
6. Upper level of sensory anaesthesia after 10 minutes. 
7. Incidence of nausea and vomiting.
8. Supplemental oxygen requirement.
9. Total duration of surgery.
After delivery of the baby, blood pressure and heart rate were maintained 
by infusing fluids and vasopressors and the umbilical cord was clamped 
at  two  ends,  blood  samples  were  taken  from  umbilical  artery  and 
umbilical vein for blood gas analysis.
Bradycardia was treated with injection atropine 0.3 mg IV, if the 
heart rate was below 50 per minute and oxygen was supplemented if the 
oxygen saturation dropped below 95%.
POST OPERATIVE OBSERVATION:
    Immediately after the surgery, Pulse rate and blood pressure were 
recorded. Patients were transferred to recovery room and observed till the 
time of total regression of analgesia and recovery from motor paralysis. 
Blood pressure and pulse rate were recorded at regular intervals of 30 
mins.
    Once the patient is recovered and the vital functions are stable, patients 
were transferred to post-operative ward. In the post-operative ward the 
vital parameters were monitored. Patients were followed up till discharge.
Statistical Tools 
The  information  collected  regarding  all  the  selected  cases  were 
recorded in  a  Master  Chart.  Data  analysis  was  done with the  help of 
computer  using  Epidemiological  Information  Package  (EPI  2002) 
developed by Centers for Disease Control and Prevention (CDC), Atlanta 
for W.H.O.
Using this software, frequencies, percentage, range, mean, standard 
deviation, x2 and 'p' values were calculated. A 'p' value less than 0.05 is 
taken to denote significant relationship
OBSERVATION AND RESULTS
Table 1: Age distribution
Age group INF Group CON Group
No. % No. %
Upto 20 2 4 - -
21-25 33 66 40 80
26-30 14 28 10 20
>30 1 2 - -
Total 50 100 50 100
Range
Mean
S.D.
20-32
24.2
2.9
21-27
24.1
1.7
‘p’ 0.5844   Not significant
The demographic data of the patients included in this study showed 
no significant difference between both groups.
Table 2 :  Pre operative parameters
Variables 
(preoperative)
INF group CON group ‘p’
Mean SD Mean SD
Systolic BP 121.6 9.6 122.4 8.6 0.5163 
not 
significant
Diastolic BP 77.7 5.8 76.8 4.3 0.5012 
not 
significant
Pulse rate 82.2 5.9 80 8.6 0.5101 
not 
significant
The preoperative parameter showed no significant difference in the 
systolic  blood pressure,  diastolic  blood pressure  and the  pulse  rate 
between the two groups. 
Table 3 : Intra operative BP from SAB to delivery
Intra operative 
BP
INF group CON group ‘p’
Mean SD Mean SD
At 1 min 122.1 9.7 121.4 7.9 0.5215  (NS)
At 2 min 117.5 13.1 114.8 12.7 0.2759 (NS)
At 3 min 121.8 16.0 106.5 11.8 0.0001( S)
At 4 min 124.2 10.7 105.1 9.8 0.0001 (S)
At 5 min 126 9.6 99.8 11.0 0.0001(S)
At 6 min 124.8 13 92 7.2 0.0001 (S)
At 7 min 125.6 10 102 9.9 0.0001 (S)
At 8 min 120.7 12.8 111.6 9.0 0.0008 (S)
At 9 min 120 11.1 120 - 0.8383 (NS)
S: significant
NS: not significant
In the infusion group systolic  blood pressure was maintained to 
normal.  There was statistically  significant  difference  in the systolic 
blood  pressure  between  the  two  groups,  from  3rd minute  till  the 
delivery of the baby with a ‘p’ value of 0.0001
Table 4 : Intra operative PR  from SAB to delivery
Intraoperative PR INF group CON group ‘p’
Mean SD Mean SD
At 1 min 82.2 9 80.3 11.6 0.5101 (NS)
At 2 min 77.4 10 78.3 11.2 0.7347 (NS)
At 3 min 70.8 8.9 80.4 12.2 0.0001 (S)
At 4 min 65.4 7.6 69.9 11.2 0.1501 (NS)
At 5 min 67.0 12.5 69.5 12.3 0.9917 (NS)
At 6 min 68.8 15.3 69.6 10.6 0.7141 (NS)
At 7 min 73.7 8.4 72.3 8.9 0.4446 (NS)
At 8 min 75.7 7.6 65.1 7.4 0.0001 (S)
At 9 min 71.5 8.3 60 - 0.227 (NS)
S: significant
NS: not significant
Pulse  rate  changed  according  to  the  usage  of  the  drug.  There  was 
statistical difference in the pulse rate at the 3rd  and 8th minute with a ‘p’ 
value of 0.0001.
Table 5 : Time interval from SAB
Time ( in minutes) INF group CON group ‘p’
Mean SD Mean SD
From SAB to Skin 
incision
4.22 0.42 4.8 0.4 0.0001 (S)
From skin to uterus 2.28 0.45 2.02 0.14 0.0003 (S)
From uterus to baby 
delivery
1.14 0.35 1.0 0 0.0063 (S)
Total time from SAB 
to Baby delivery
7.64 0.75 7.82 0.44 0.0501 
(NS)
S: significant
NS: not significant
The time interval between the SAB to skin incision, skin to uterus 
incision,  uterus  incision  to  baby  delivery  time  showed  statistically 
significant difference. But the total time between the SAB to the baby 
delivery showed no significant difference. The average time was 7.6 min 
in the infusion group compared to 7.8 minutes in the control group.
Table 6: Total dose of Phenylephrine
Total dose of 
Phenylephrine 
in µg
INF group CON group
NO % NO %
Upto 200 - - 37 74
201-400 33 66 13 26
401- 600 17 34 - -
>600 - - - -
Range
Mean
SD
300-600
402
91.5
100-300
212
62.2
‘p’ 0.0001 significant
The total dosage in the infusion group ranged between 300 to 600 
µg. In the control group it ranged between 100 to 300µg. The difference 
between  the  2  groups was  statistically  significant  with  a  ‘p’  value  of 
0.0001.
Table 7: APGAR Score
APGAR 
Score
INF group CON group
NO % NO %
1 minute
5
6
7
8
-
5
34
11
-
10
68
22
1
15
34
-
2
30
68
-
Range
Mean
SD
5-8
7.12
0.56
5-7
6.66
0.52
‘p’ 0.0001 significant
At 5 minutes
7
8
9
3
36
11
6
72
22
3
46
1
6
92
2
Range
Mean
SD
7-9
8.16
0.51
7-9
7.96
0.28
‘p’ 0.0001 - significant
The APGAR score at the 1st and the 5th minute showed better in the 
infusion group and that was also statistically significant. It was 7.1 at 1st 
minute in the infusion group compared to 6.6 in the control group. It was 
8.6 at 5th minute in the infusion group compared to 7.9 in the control 
group. APGAR scores were significant between the two groups in the 1st 
and 5th minute with a ‘p’ value of 0.0001.
Table 8: ABG pH values
pH values Inf. Group Con. Group ‘p’
Range Mean S.D. Range Mean S.D.
Umbilical 
artery pH
7.26-7.32 7.31 0.01 7.28-7.34 7.30 0.02 0.4337
(NS)
Umbilical 
vein pH
7.33-7.39 7.36 0.02 7.33-7.39 7.35 0.02 0.8771
(NS)
Table 9: PCO2 values
PCO2 
values
Inf. Group Con. Group ‘p’
Range Mean S.D. Range Range S.D.
Umbilical 
artery PCO2
48-58 51 2.7 49-56 53 2.2 0.0543
(NS)
Umbilical 
vein PCO2
40-48 44 1.9 40-48 44 1.9 0.7889
(NS)
S: significant
NS: not significant
The  umbilical  cord  blood  gas  values  showed  no  significant 
difference  between both the  groups,  and they were comparable  to  the 
standard values.
Table 10: Atropine usage
Incidence of 
atropine 
usage
INF group CON group
Total NO. % Total NO. %
YES 11 22 23 46
NO 39 78 27 54
‘P’ 0.0202 SIGNIFICANT
The usage of atropine was more in the control group which means 
that  22% of the  patients  had bradycardia  in  the infusion group which 
required  treatment  and  46% of  patients  in  the  control  group  required 
treatment  with  Atropine  which  was  statistically  significant  with  a  ‘p’ 
value of 0.0202.
Table 11: Nausea /Vomiting
Incidence of 
Nausea /Vomiting
INF group CON group
Total NO. % Total NO. %
Yes - - - -
No 50 100 50 100
‘p’ -
There was not even a single case of nausea and vomiting in both 
the groups.
Table 12: Total episodes of Hypotension
Total 
episodes of 
hypotension
INF group CON group
NO % NO %
0 16 32 - -
1 8 16 6 12
2 24 48 31 62
3 1 2 13 26
4 1 2 - -
Range 0-4 1-4
Mean 1.26 2.14
SD 1.0 0.61
‘p’ 0.0001 significant
In  the  infusion  group  32%  of  the  cases  did  not  have  a  single 
episode of hypotension. In the control group all cases had hypotension. 
But both in the infusion and the control group there were maximum cases 
which had 2 episodes of hypotension.  There was 48% of cases in the 
infusion group and 62% of cases in the control group. The mean episode 
of hypotension was 1.2 in the infusion group and 2.1 in the control group 
which was statistically significant with a ‘p’ value of 0.0001.
DISCUSSION
          The commonly used techniques for cesarean section are general 
anaesthesia,  epidural  anaesthesia,  and  spinal  anaesthesia.   There  are 
advantages as well as disadvantages in all  these techniques. Whenever 
there is  necessity  for  rapid induction like  in  fetal  distress,  antepartum 
hemorrhage or placenta previa general anaesthesia is indicated. Also in 
general  anaesthesia,  there  will  be  less  chances  of  hypotension,  more 
cardiovascular stability and better control of airway and ventilation. But 
there  are  some  disadvantages  in  general  anaesthesia  like  maternal 
aspiration, sympathetic stimulation during laryngoscopy and intubation, 
awareness during anaesthesia and intubation difficulty in pregnancy. To 
over come these problems, spinal anaesthesia or epidural anaesthesia are 
the solutions. But in epidural anaesthesia there are many disadvantages 
like failure  even in expert  hands,  delay in onset  time,  accidental  total 
spinal  anaesthesia,  patchy  analgesia  and  height  of  analgesia  is  not 
predictable.  So spinal  anaesthesia  is now commonly used for  cesarean 
sections especially in emergency cases.
             There  are  many  advantages  and disadvantages  of  spinal 
anaesthesia over general anaesthesia. 
ADVANTAGES:
 1. Administered easily
2. High success rate
3. Produces rapid, reliable and profound anaesthesia
4. Fulfillment of mothers desire to stay awake
5. Avoidance of depressant drugs to the mother and subsequently to the 
fetus
6. Operative blood loss is less with regional anaesthesia
DISADVANTAGE: 
1.  Spinal  anaesthesia  induced  hypotension  will  aggravate  the  supine 
hypotension syndrome of pregnancy. 
2. Onset and time required for anaesthesia induction is less suitable when 
surgical indication is urgent.
                 Hypotension is associated with comparable fall in uterine 
blood  flow  and  placental  perfusion  leading  to  fetal  hypoxemia  and 
acidosis if not promptly treated. Abnormal APGAR, fetal acidosis and 
neurobehavioural  scores  were  noted  when  maternal  systolic  blood 
pressure dropped by more than 30% of baseline or stayed less than 80mm 
Hg for more than 4 minutes.  Spinal anaesthesia also causes fetal heart 
rate distortions due to decline in the utero-placental blood flow. Spinal 
anaesthesia decreases the intervillous blood flow which is a measure of 
the changes in the uteroplacental blood flow in humans.
               Prophylaxis against rather than treatment of this hypotension is  
important not only in the interests of fetal well being, but because even 
transient  hypotension  by  inducing  maternal  nausea  and  vomiting  can 
undermine her confidence in the procedure and thus convert enjoyable 
and satisfying experience into a harrowing one for all concerned.
           This study confirmed the clinical  impression that starting a 
prophylactic infusion of Phenylephrine immediately after the induction of 
spinal anesthesia for cesarean delivery would be effective at reducing the 
incidence, frequency, and severity of hypotension. It is noteworthy that in 
the  infusion  group,  despite  the  administration  of  a  large  total  dose  of 
Phenylephrine, the fetal acid-base status and clinical condition of infants 
were excellent and similar to those in the control group. Although it was 
found that a prophylactic infusion of Phenylephrine was effective,  and 
was not associated with a detrimental effect on fetal acid-base status, it 
did not eliminate hypotension completely. This is partly explained by the 
limitations of our standardized study protocol. The study was  designed to 
be as simple as possible, with one criterion for starting and stopping the 
infusion and one set infusion rate. Of note, in the infusion group who had 
one or more episodes of hypotension, the hypotension occurred after the 
initial  infusion was stopped. In these cases,  although the infusion was 
restarted  when  SBP  decreased  to  less  than  baseline  again,  because 
Phenylephrine  has  latency  for  effect,  transient  hypotension  occurred. 
Large total doses of Phenylephrine in the infusion group were used  and 
in this group SBP increased transiently to values more than baseline in 
some patients. This may cause concern about potential adverse effects on 
uteroplacental  blood  flow.  However,  uteroplacental  flow  or  resistance 
was not directly assessed, the high values for umbilical artery and venous 
pH in the present study are indirect evidence that there was no significant 
adverse effect. However, it should be noted that it was studied only in 
healthy patients undergoing emergency cesarean deliveries. It may not be 
valid to extrapolate our findings to patients with nonreassuring fetal HR 
patterns or impaired uteroplacental blood flow, to preeclamptic patients, 
or to patients with a very prolonged induction-to-delivery time.
HEMODYNAMIC PROFILE:
              It was found that maternal HR was statistically significantly 
slower in the control group compared to the infusion group contrary to 
the study done by the Ngan kee et al. This could be attributed to the rate 
of injection of the drug which was faster in the bolus group. However, 
because  these  cases  were  not  associated  with  hypotension,  the  likely 
mechanism was a baroreceptor reflex. There were no associated adverse 
clinical sequelae. Atropine was used in 11 of the 50 cases in the infusion 
group compared to 23 of the 50 cases in the control group. All the cases 
required only one dosage of atropine of 0.3 mg.
           The maternal systolic blood pressure was maintained till the 
delivery  of  the  baby  in  the  infusion  group,  but  in  the  control  group 
systolic  blood  pressure  decreased  and  this  decrease  was  statistically 
significant every minute till the delivery of the baby with a ‘p’ value of 
0.0001. In one case in the infusion group there was an increase in the 
blood pressure as soon as the infusion was started to more than 20% of 
the base line in that case it was a failed subarachnoid block which needed 
a repeat spinal. This case was excluded from the study group. The blood 
pressure became normal in 5 minutes 
The time interval between the SAB to skin incision, skin to uterus 
incision,  uterus  incision  to  baby  delivery  time  showed  statistically 
significant difference. But the total time between the SAB to the baby 
delivery showed no significant difference. The average time was 7.6 min 
in the infusion group compared to 7.8 minutes in the control group.
The total dosage in the infusion group ranged between 300 to 600 µg. 
In the control group it ranged between 100 to 300µg. The difference 
between the 2 groups was statistically significant with a ‘p’ value of 
0.0001.
In  the  infusion  group  32%  of  the  cases  did  not  have  a  single 
episode of hypotension. In the control group all cases had hypotension. 
But both in the infusion and the control group there was maximum cases 
which  had  2  episodes  of  hypotension  there  was  48% of  cases  in  the 
infusion group and 62% of cases in the control group. The mean episode 
of hypotension was 1.2 in the infusion group and 2.1 in the control group 
which was statistically significant with a ‘p’ value of 0.0001. Despite a 
more frequent incidence of hypotension in the control group, it was found 
that  fetal  acid-base  status  was  not  worse  compared  with  that  in  the 
infusion  group.  This  likely  reflects  the  fact  that  when  hypotension 
occurred, it was treated promptly with boluses of Phenylephrine. In this 
study hypotension was defined as a decrease in SBP by more than 20% 
less than baseline. However, the exact degree of hypotension that should 
be treated is undetermined.
FETAL PROFILE:
The APGAR score at the 1st and the 5th minute showed better in the 
infusion group and that was also statistically significant. It was 7.1 at 1st 
minute in the infusion group compared to 6.6 at the same time in the 
control group .It was 8.6 at 5th minute in the infusion group compared to 
7.9 at the same time in control group. It was significant with a ‘p’ value 
of 0.0001.
 The  umbilical  cord  blood  gas  values  showed  no  significant 
difference between both the groups. And they were comparable to the 
standard values. There was not a single patient who reported with nausea 
or  vomiting.  This  may  be  attributed  to  the  Inj.Metoclopramide  10mg 
given as a premedication. The level of block measured at 10 minutes was 
one  segment  higher  in  the  infusion  group  compared  with  the  control 
group. Although the clinical significance of a one-segment difference in 
block height is uncertain, because a higher block level might result in a 
greater degree of sympathetic block, this should have predisposed to a 
more frequent incidence of hypotension in the infusion group compared 
with  the  control  group.  But  this  did  not  happen  because  of  the 
prophylactic Phenylephrine given in the infusion group. 
                        SUMMARY
The aim of this  study is  to prospectively compare two methods of 
administration  of  Phenylephrine,  Infusion vs Bolus dose  in prevention 
and  treatment  of  hypotension  in  cesarean  section  under  spinal 
anaesthesia.100  patients,  all  primi  gravidas  undergoing  emergency 
cesarean section under subarachnoid block were randomly divided into 
two  groups.  In  the  infusion  group,  Phenylephrine  100µg  /min  was 
infused for the initial 3 minutes after the subarachnoid block and were 
supplemented with 100µg infusion, whenever the systolic blood pressure 
was  below  the  baseline  value.  In  the  control  group,  Phenylephrine 
100µg bolus was given when the systolic blood pressure decreased below 
20% of the baseline value. The following were noted and recorded.
1. Pulse rate and blood pressure every one minute until delivery of the 
baby and every five minutes thereafter.
2. The time interval between subarachnoid block to skin incision, skin 
incision to uterine incision, and uterine incision to delivery of baby. 
3. APGAR scores at 1 minute and 5 minutes to assess neonatal outcome.
4. Total dose of the Phenylephrine used until the delivery of the baby in 
both groups.
5. Total episodes of the hypotension.
6. Incidence of nausea and vomiting.
The following results were obtained. Of the 2 groups compared
1. Age and preoperative baseline parameters  were comparable  in both 
groups. 
2. Blood pressure: There was significant difference in the magnitude of 
hypotension  between  both  the  groups  with  less  hypotension  in  the 
infusion  group.  In  the  infusion  group  systolic  blood  pressure  was 
maintained to normal, there was statistically significant difference in 
the systolic blood pressure between the 3rd minute till the delivery of 
the baby. 
3. Pulse  rate  changed according to  the  usage  of  the  drug.  There  was 
statistical difference in the pulse rate at the 3rd  and 8th minute. It was 
better in the infusion group.
4. The total dosage in the infusion group ranged between 300 to 600 µg. 
In the control group it ranged between 100 to 300µg. The difference 
between the 2 groups was statistically significant.
5. Fetal outcome measured by APGAR score was better in the infusion 
group and it was clinically significant. At the same time fetal acid base 
status showed no significant difference, it was excellent in both the 
groups.
6. The usage of atropine was more in the control group compared to the 
infusion group. 
         CONCLUSION
In  conclusion,  these  data  suggest  that  a  prophylactic 
Phenylephrine  infusion  is  an  effective  and  simple  method  of 
reducing the incidence and magnitude of hypotension during spinal 
anesthesia for cesarean delivery with no adverse effect on neonatal 
outcome when compared to Phenylephrine bolus usage.
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PROFORMA
NAME: AGE:  
IPNO:
DIAGNOSIS: G/P/L/A:
PROCEDURE:
ASA:      I / II
PREMEDICATION: Inj.Ranitidine 50 mg iv
                                 Inj.Metoclopramide 10 mg iv
PRE OP BP :  I : II: III: MEAN:  
    80%VALUE:
              HR:  I:               II:              III:           MEAN:
No IV Prehydration
IV RL solution @5 ml/min
SAB LEVEL:   L2-L3
        GAUGE: 25G
        VOLUME 1.8 ML OF 0.5% HYPERBARIC BUPIVACAINE
TIME OF SAB:
Patient turned supine
Left uterine displacement
No routine preoxygenation
GROUP:                                      INFUSION/CONTROL
INFUSION: Phenylephrine 100µg/min for the initial 3 min, and 100µg 
whenever the systolic blood pressure goes below the   baseline value
CONTROL: Phenylephrine 100µg whenever the systolic blood pressure 
goes below 20% of the baseline value
Upper sensory level of anaesthesia by loss of pinprick sensation: 
T2/T4/T6/T8
Treat bradycardia if HR <50 with Atropine 0.3 mg
Supplement oxygen if SPO2 < 95%
TIME SYSTOLIC BP HR SPO2 PHENYLEPHRINE
1ST MIN
2 MIN
3 MIN
4 MIN
5 MIN
6 MIN
7 MIN
8 MIN
9 MIN
10 MIN
TIME OF SKIN INCISION:
TIME OF UTERINE INCISION:
TIME OF BABY DELIVERY:
TOTAL DOSE UNTIL THE BABY DELIVERY:
APGAR SCORE: 1 MIN: 5 MIN:
ABG ANALYSIS:
INCIDENCE OF NAUSEA/VOMITING YES/NO
TOTAL SURGERY DURATION:
SUPPLEMENTAL OXYGEN: YES/NO
TOTAL PHENYLEPHRINE USED:
TOTAL EPISODES OF HYPOTENSION:
STRUCTURE OF BUPIVACAINE
STRUCTURE OF PHENYLEPHRINE
